NCT04308759

An Innovative Conversational Agent (Quitbot) for Smoking Cessation

Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)

• Status: Active Not Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,647 (actual)
• Sponsor: Fred Hutchinson Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.

Detailed description

OUTLINE: Participants are randomized to 1 of 2 groups. Both groups receive access to a 42-day quit smoking program. GROUP I: Experimental program, for 42 days to support quitting smoking. After the completion of study, patients are followed up at 3, 6, and 12 months. GROUP II: Control program, for 42 days to support quitting smoking. After the completion of study, patients are followed up at 3, 6, and 12 months.

Conditions

• Cigarette Smoking-Related Carcinoma

Interventions

Type	Name	Description
OTHER	Experimental Smoking Cessation Program	Participate in Quitbot experimental cessation program
OTHER	Control Smoking Cessation Program	Participate in Quitbot control cessation program

Timeline

• Start date: 2022-07-24
• Primary completion: 2025-05-01
• Completion: 2026-05-01
• First posted: 2020-03-16
• Last updated: 2025-05-28

Locations

1 site across 1 country: United States